Protagonist Therapeutics Inc (PTGX)
Fixed asset turnover
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (ttm) | US$ in thousands | 434,433 | 323,795 | 319,120 | 314,953 | 60,000 | 0 | 0 | 859 | 26,581 | 35,198 | 45,484 | 46,890 | 27,357 | 24,390 | 27,218 | 31,170 | 28,628 | 25,697 | 16,724 | 2,318 |
| Property, plant and equipment | US$ in thousands | — | — | — | — | — | — | 1,263 | 1,341 | 1,565 | 1,783 | 1,962 | 2,064 | 6,734 | 1,723 | 6,067 | 1,432 | 1,462 | 6,694 | 7,064 | 7,383 |
| Fixed asset turnover | — | — | — | — | — | — | 0.00 | 0.64 | 16.98 | 19.74 | 23.18 | 22.72 | 4.06 | 14.16 | 4.49 | 21.77 | 19.58 | 3.84 | 2.37 | 0.31 |
December 31, 2024 calculation
Fixed asset turnover = Revenue (ttm) ÷ Property, plant and equipment
= $434,433K ÷ $—K
= —
Protagonist Therapeutics Inc's fixed asset turnover has exhibited significant fluctuations over the analyzed periods. The ratio was consistently low in the initial periods, suggesting inefficient utilization of fixed assets to generate revenue. However, from December 31, 2020, to June 30, 2022, there was a remarkable increase in the fixed asset turnover, indicating a more efficient management of fixed assets in generating sales.
The peak in fixed asset turnover was observed in March 31, 2022, with a value of 23.18, signifying that Protagonist Therapeutics Inc was able to generate $23.18 in sales for every dollar invested in fixed assets.
Subsequently, there was a decline in the fixed asset turnover ratio in the latter part of the analysis period, falling to 0.00 as of June 30, 2023. This abrupt drop may be due to various factors such as changes in the company's business model, depreciation of assets, or decreased revenue generation efficiency.
The missing data points from September 30, 2023, to December 31, 2024, make it challenging to provide a complete trend analysis. It is recommended for Protagonist Therapeutics Inc to assess the reasons behind the fluctuating fixed asset turnover and take appropriate actions to optimize the utilization of their fixed assets effectively.
Peer comparison
Dec 31, 2024